Literature DB >> 21335249

Trends in renal replacement therapy in Turkey, 1996-2008.

Gültekin Süleymanlar1, Kamil Serdengeçti, Mehmet R Altiparmak, Kitty Jager, Nurhan Seyahi, Ekrem Erek.   

Abstract

BACKGROUND: National renal registry studies providing data for incidence, prevalence, and characteristics of end-stage renal disease and renal replacement therapy (RRT) serve as a basis to determine national strategies for the prevention and treatment of these diseases and identify new areas for special studies. STUDY
DESIGN: Since 1990, the Turkish Society of Nephrology has been coordinating a national renal registry that collects data on patients receiving RRT. This report focuses on data collected from 1996-2008. SETTING & PARTICIPANTS: Data were collected in dialysis centers for patients on RRT. PREDICTOR: Year. OUTCOMES: Point prevalence and incidence of RRT, RRT modalities, demographic and clinical characteristics of patients on RRT.
RESULTS: From 1996 to 2008, the number of centers (199 and 760) and response rates to the registry (76% and 99.4%) increased. In 2008, the point prevalence of RRT was 756 per million population (pmp) and incidence was 188 pmp, including pediatric patients. In prevalent patients, the most common RRT modality was hemodialysis (77.0% of patients), followed by peritoneal dialysis (10.1%) and transplant (12.9%). The age of hemodialysis and transplant patients increased, with a predominance of male patients. Percentages of diabetes mellitus and hypertension as causes of ESRD increased, whereas those of chronic glomerulonephritis and urologic disease decreased. Infection and crude death rates decreased in all treatment modalities. LIMITATIONS: The main study limitations were registry design and low number of kidney transplants.
CONCLUSION: With increasing numbers of dialysis centers and RRT patients during the last 12 years, the need for RRT in Turkey has been better met. The quality of RRT care has improved, especially regarding prevention and treatment of infections.
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21335249     DOI: 10.1053/j.ajkd.2010.12.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Comparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation.

Authors:  Ozan Ekmekçioğlu; Sadi Turkan; Şener Yıldız; Zeki Ender Güneş
Journal:  Turk J Urol       Date:  2013-03

2.  The Prevalence of Potential Drug-Drug Interactions in CKD-A Retrospective Observational Study of Cerrahpasa Nephrology Unit.

Authors:  Andleeb Shahzadi; Ikbal Sonmez; Cagla Kose; Burhaneddin Oktan; Selma Alagoz; Haktan Sonmez; Adil Hussain; Ahmet Gokhan Akkan
Journal:  Medicina (Kaunas)       Date:  2022-01-26       Impact factor: 2.430

3.  Hypertension and chronic kidney disease in Turkey.

Authors:  Sule Sengul; Yunus Erdem; Vecihi Batuman; Sehsuvar Erturk
Journal:  Kidney Int Suppl (2011)       Date:  2013-12

4.  Long-term clinical outcomes of peritoneal dialysis patients: 9-year experience of a single centre in Turkey

Authors:  Nihan Tekkarişmaz; Dilek Torun
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

5.  Incidence of end-stage renal disease in the Turkish-Cypriot population of Northern Cyprus: a population based study.

Authors:  Thomas M F Connor; D Deren Oygar; Daniel P Gale; Retha Steenkamp; Dorothea Nitsch; Guy H Neild; Patrick H Maxwell
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.